Countries: Afghanistan, Argentina, Australia, Brazil, Canada, China, Egypt, France, Germany, India, Japan, Kenya, Mexico, Netherlands, Philippines, Poland, Russia, Saudi Arabia, Singapore, South Africa, Sweden, Thailand, United Kingdom, United States of America, Vietnam
Topic A: Corporate and state responsibility in chemical waste disposal
Chemical waste is contains harmful chemicals, usually produced by large factories, and must be disposed off properly to avoid environmental catastrophes. Increased levels of these toxic chemical waste in an environment can cause genetic defects, diseases, nausea and many more seriously harmful issues including death that impact human life as well as other life forms who come into contact with it. Commonly toxic chemical waste is exported from developed countries to developing countries, and forgotten about. This procedure is known as toxic colonialism and helps wealthier nations and corporations get rid of the dangerous, polluting waste. These are able to suppress any allegations of wrongdoing when the soil and rivers become poisoned and local populations start showing symptoms of toxic exposure, and potentially dying. This is made possible due to the complexity and vitality of the matter, international action would seem to be the only way to substantively address the matter, bring about the necessary changes and enforce accountability. The Legal Committee should take into consideration previous international legislature on similar measures to guide the discussion.
Topic B: Tackling the illegal and substandard medication in LEDC’s
If a prescription drug is considered unfit or dangerous to use, having failed the quality measurements and legal standards it is labeled as substandard medication. Recently, use of substandard medications has been increasing rapidly, with reported increases of use being 42% within Africa, 21% within the Americas, 21% within Europe and 16% within Asia in 2013. However, these figures are believed to be only a small percentage of the actual usage, and are thought to be much higher, specifically in LEDCs. According to the WHO, 1 out of 10 circulating medical products in LEDCs is falsified. Due to the now often globalized production process, it has become increasingly harder to control the trade and quality of medication.
To prevent the further proliferation and usage of such medication the WHO created the Global Surveillance and Monitoring System (GSMS) in 2013, and trained 550 regulators in 144 countries, prior to which there was no monitoring system. Although some progress has been made, there is still a long way to go before the problem is fully eradicated, thus delegates of the Legal Committee are invited to form a resolution to extend the GSMS as well as tackling the root of the problem.